CoreRx, a leader in early drug contract development, has expanded manufacturing capabilities to include 15-cubic foot and 30-cubic foot V-shell blenders, a 43-station high speed tablet press, high speed encapsulation and a 40-inch solvent-capable coating pan. The additional equipment train will allow for increased clinical batch sizes in support of growing client demand.  The additional equipment will allow CoreRx scientists to manufacture batch sizes of up to one million solid dosage units per day.

CoreRx, fast becoming a world-recognized leader in early drug contract development, was announced today as one of Tampa Bay’s Fast 50  companies. The Tampa Bay Business Journal’s Fast 50 is a list of the  fastest growing privately held companies in Tampa Bay over a span of  three years. Last year, CoreRx was recognized as the  6th fastest growing company in the Tampa Bay region.

Clinical trial materials are already targeted and scheduled for processing in Q3, 2008. The GMP process rooms will feature a new tri-layer tablet press, high shear granulator, fluid bed dryer/granulator, bin tumbler, and co-mill. CoreRx also announces the addition of two new state of the art formulation development suites and the addition of new formulation development process equipment including laboratory fluid bed dryer/granulator, laboratory high shear granulator, laboratory tablet coater, spray dryer and various other process equipment.